Answers are grounded in this paper and cite their sources.
The first vaccines against SARS-CoV-2 have now received emergency use authorization by the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and national authorities in China, India, UK, and Russia; and are rapidly being distributed in more than 30 countries since the end of the 2020. So far vaccines are being used by the respective countries after national approval based on promising efficacy reports and safety data, however, data on some of these vaccines have not yet been published in international peer-reviewed journals.
No takes yet. Share an insight, caveat, or question.
Petersen et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: